SPRY - ARS Pharmaceuticals, Inc.

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 8.35

Open

$ 8.19

Bid

$ 0.00 x 0

Ask

$ 8.37 x 400

Day's Range

$ 8.19 - $ 8.66

52 Week Range

$ 2.55 - $ 11.27

Volume

520,298

Average Volume

Market Cap

805.79M

Beta (5Y Monthly)

$ 1.02

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-21-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-10-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	03-23-2023	12-31-2022	10-K
6	11-02-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-31-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-12-2021	06-30-2021	10-Q
12	05-13-2021	03-31-2021	10-Q
13	03-29-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

ARS Pharmaceuticals Submits Response To FD...
04/03/2024 13:04:33

Response addresses all additional requests in FDA CRL, including positive data from a repeat dose PK/PD study of neffy under na...

top-5-health-care-stocks-that-may-plunge-in-march

Top 5 Health Care Stocks That May Plunge I...
03/28/2024 12:30:01

As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as...

CORRECTION: On Thursday March 21, 2024 ARS...
03/22/2024 20:15:19

ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $...

Wedbush Reiterates Outperform on ARS Pharm...
03/11/2024 12:46:43

Wedbush analyst Andreas Argyrides reiterates ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperform and maintains $19 price tar...

ARS Pharmaceuticals Reviews Recent Clinica...
03/07/2024 21:36:03

Significant unmet need with 80-90% of patients with current epinephrine Rx not using as directed, and only ~15% of diagnosed se...

Leerink Partners Upgrades ARS Pharmaceutic...
03/05/2024 12:11:58

Leerink Partners analyst Roanna Ruiz upgrades ARS Pharmaceuticals (NASDAQ:SPRY) from Market Perform to Outperform and raises...

allergic-reaction-focused-ars-pharmaceuticals-lead-candidate-shows-efficacy-in-skin-disorder

Allergic Reaction Focused ARS Pharmaceutic...
02/26/2024 19:12:43

ARS Pharmaceuticals reports Phase 2 study results for neffy (epinephrine nasal spray) treating chronic spontaneous urticaria. S...

ARS Pharmaceuticals Announces neffy Meets ...
02/26/2024 14:03:53

neffy demonstrated statistically significant and clinically meaningful improvement in pruritus, hives, body surface area and er...

ars-pharma-readies-data-in-response-to-fdas-rejection-for-its-epipen-alternative-for-severe-allergic-reactions

ARS Pharma Readies Data In Response To FDA...
02/20/2024 19:53:53

NAC study results by ARS Pharma comparing neffy (epinephrine nasal spray) to intramuscular injection. Data submission is expect...

ARS Pharma Announces Topline Results From ...
02/20/2024 14:03:11

Repeat doses of neffy under nasal allergen challenge demonstrate a pharmacokinetic profile greater than or similar to injection...

ARS Pharmaceuticals To Present Clinical Ef...
02/05/2024 14:02:41

Six posters and oral presentations to be presented, including efficacy data for neffy from two distinct clinical studies in ora...

Wedbush Maintains Outperform on ARS Pharma...
11/13/2023 14:00:54

Wedbush analyst Andreas Argyrides maintains ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperform and raises the price target ...

why-wynn-resorts-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Wynn Resorts Shares Are Trading Lower ...
11/10/2023 18:34:32

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.

big-stocks-moving-higher-on-friday-synaptics-reports-q1-beat-joins-lyft-hologic-blink-charging

Big Stocks Moving Higher On Friday: Synapt...
11/10/2023 16:51:36

U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Friday. Shares of Synaptics Incorporated (NASDAQ: S...

ARS Pharmaceuticals Q3 EPS $(0.16) Up From...
11/09/2023 21:43:29

ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.16) per share. This is a 23.81 percent increase over losses ...

ARS Pharmaceuticals Announces Presentation...
11/09/2023 16:05:30

Data to be Presented in Four Oral Presentations and Posters at the 2023 American College of Allergy, Asthma and Immunology Annu...

ARS Pharmaceuticals Announces Scheduling O...
10/06/2023 13:04:49

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to...

ARS Pharmaceuticals Announced The Publicat...
10/03/2023 13:06:29

neffy resulted in robust responses on pharmacodynamic (PD) surrogates of efficacy observed even at 1 minute after dosing, and w...

why-td-synnex-shares-are-trading-lower-by-over-5-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why TD SYNNEX Shares Are Trading Lower By ...
09/26/2023 16:56:35

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results...

Fisker, Intercept Pharmaceuticals, Immunov...
09/26/2023 14:49:13

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in ...